Bushe Christopher, Wilson Bernard, Televantou Foula, Belger Mark, Watson Louise
Lilly UK, Erl Wood Manor, Windlesham, Surrey.
Lilly UK, Lilly House, Basingstoke, Hampshire.
Pragmat Obs Res. 2015 Jan 23;6:1-12. doi: 10.2147/POR.S74161. eCollection 2015.
Adult attention deficit hyperactivity disorder (ADHD) has been largely ignored in psychiatric and general practice guidance until recently. Adult ADHD has a high social and medical burden, but health care is not well described in the UK. The main study objective was to evaluate a primary care adult ADHD population in terms of prescribing and health care contact rates.
This was a retrospective observational study using data from the Clinical Practice Research Database from January 1, 2002 to July 31, 2011. Adult patients with an incident ADHD diagnosis or ADHD medication were identified as having been free of ADHD medication or diagnoses in the previous 2 years. Patients were followed for 12-24 months after diagnosis.
Of the 663 patients with ADHD in the cohort, 54.1% were prescribed ADHD medication during the observation period. During the first 6 months, 34.2% of patients initiated methylphenidates and 14.0% atomoxetine. In total, 36.3% patients were referred to secondary care psychiatry during observation, with the remaining population (63.7%) never having a referral. Most of the referrals were before diagnosis in primary care. At the end of the observation period, 16.2% of patients were on antipsychotics, 17.3% hypnotics, and 34.8% antidepressants or anxiolytics; however, some patients appeared to be prescribed antipsychotic or antidepressant medications even if they did not have an observable diagnosis in their records. Health care contact rates (general practitioner or hospital) increased by 39.2% post-diagnosis (incidence rate ratio: 1.39; 95% confidence interval: 1.32, 1.47), which may be related to the need for medication monitoring and titration.
This study has shown in primary care that there is relatively low use of ADHD medication, low referrals into secondary care, high rates of usage of psychiatric non-ADHD medications for different indications, and an increasing burden in terms of health care contacts in adult ADHD patients post-diagnosis.
成人注意力缺陷多动障碍(ADHD)在精神科和普通医疗实践指南中一直 largely 被忽视,直到最近。成人ADHD具有很高的社会和医疗负担,但在英国,医疗保健情况并未得到很好的描述。主要研究目标是从处方和医疗保健接触率方面评估初级保健中的成人ADHD人群。
这是一项回顾性观察研究,使用了临床实践研究数据库中2002年1月1日至2011年7月31日的数据。确诊患有ADHD或正在服用ADHD药物的成年患者被确定为在过去两年中未服用ADHD药物或未被诊断出患有ADHD。患者在诊断后随访12 - 24个月。
在该队列中的663例ADHD患者中,54.1%在观察期内被开具了ADHD药物。在最初的6个月里,34.2%的患者开始使用哌甲酯,14.0%的患者开始使用托莫西汀。在观察期间,共有36.3%的患者被转诊至二级护理精神科,其余人群(63.7%)从未被转诊。大多数转诊发生在初级保健诊断之前。在观察期结束时,16.2%的患者正在服用抗精神病药物,17.3%的患者正在服用催眠药物,34.8%的患者正在服用抗抑郁药或抗焦虑药;然而,一些患者即使在其记录中没有可观察到的诊断,似乎也被开具了抗精神病或抗抑郁药物。诊断后医疗保健接触率(全科医生或医院)增加了39.2%(发病率比:1.39;95%置信区间:1.32,1.47),这可能与药物监测和滴定的需求有关。
这项在初级保健中的研究表明,ADHD药物的使用相对较低,转诊至二级护理的比例较低,针对不同适应症使用精神科非ADHD药物的比例较高,并且成人ADHD患者在诊断后的医疗保健接触负担不断增加。